|
WO2005012286A1
(en)
*
|
2003-07-25 |
2005-02-10 |
Amgen Inc. |
Substituted pyridones and pyrimidinones with antiinflammatory properties
|
|
AU2004267096B2
(en)
*
|
2003-08-20 |
2008-10-02 |
Amgen Inc. |
Substituted pyrimdinone derivatives and methods of use
|
|
KR20070091038A
(ko)
*
|
2004-12-24 |
2007-09-06 |
프로시디온 리미티드 |
Ｇ-단백질 결합 수용체(ｇｐｒ116) 효능제 및 비만 및당뇨병을 치료하기 위한 이의 용도
|
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
US8062824B2
(en)
*
|
2006-07-17 |
2011-11-22 |
E. I. Du Pont De Nemours And Company |
Thermally imageable dielectric layers, thermal transfer donors and receivers
|
|
US7528448B2
(en)
*
|
2006-07-17 |
2009-05-05 |
E.I. Du Pont De Nemours And Company |
Thin film transistor comprising novel conductor and dielectric compositions
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
EA017648B1
(ru)
|
2007-09-14 |
2013-02-28 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны
|
|
US7666568B2
(en)
*
|
2007-10-23 |
2010-02-23 |
E. I. Du Pont De Nemours And Company |
Composition and method for providing a patterned metal layer having high conductivity
|
|
US7666567B2
(en)
|
2007-10-23 |
2010-02-23 |
E. I. Du Pont De Nemours And Company |
Negative imaging method for providing a patterned metal layer having high conductivity
|
|
JP5547194B2
(ja)
|
2008-09-02 |
2014-07-09 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体
|
|
JP5690277B2
(ja)
|
2008-11-28 |
2015-03-25 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
|
|
CN102439015B
(zh)
|
2009-05-12 |
2015-05-13 |
杨森制药有限公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
HRP20131122T1
(hr)
|
2009-05-12 |
2013-12-20 |
Janssen Pharmaceuticals, Inc. |
Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
|
|
ES2536433T3
(es)
|
2010-11-08 |
2015-05-25 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
|
JP5852664B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
１，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
|
EP2661435B1
(en)
|
2010-11-08 |
2015-08-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
US9133187B2
(en)
|
2011-02-28 |
2015-09-15 |
Array Biopharma Inc. |
Serine/threonine kinase inhibitors
|
|
ES2552989T3
(es)
|
2011-08-04 |
2015-12-03 |
Array Biopharma, Inc. |
Compuestos de quinazolina como inhibidores de la cinasa de serina / treonina
|
|
EP2773207B1
(en)
|
2011-10-31 |
2018-03-07 |
Merck Sharp & Dohme Corp. |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
|
|
US10531655B2
(en)
|
2011-12-02 |
2020-01-14 |
The Regents Of The University Of California |
Reperfusion protection solution and uses thereof
|
|
PE20150666A1
(es)
|
2012-03-01 |
2015-05-06 |
Array Biopharma Inc |
Inhibidores de serina/treonina cinasa
|
|
CA2882750A1
(en)
|
2012-08-27 |
2014-03-06 |
Jim Blake |
Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
ME03518B
(me)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
|
|
PL3096790T3
(pl)
|
2014-01-21 |
2020-01-31 |
Janssen Pharmaceutica, N.V. |
Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
|
|
KR102498819B1
(ko)
*
|
2017-04-11 |
2023-02-10 |
미쓰이가가쿠 아그로 가부시키가이샤 |
피리돈 화합물 및 그것을 유효성분으로 하는 농원예용 살균제
|
|
PL3672948T3
(pl)
*
|
2017-08-23 |
2022-12-05 |
Sprint Bioscience Ab |
Związki pirydynoamino-pirydonu i pirymidynoamino-pirydonu
|
|
IL302356A
(en)
*
|
2017-08-23 |
2023-06-01 |
Sprint Bioscience Ab |
Pyridylpyridone compounds
|
|
US12479816B2
(en)
|
2019-02-08 |
2025-11-25 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
20-HETE formation inhibitors
|
|
CN117083064A
(zh)
|
2020-11-25 |
2023-11-17 |
德西费拉制药有限责任公司 |
作为vps34抑制剂用于治疗病毒感染的吡啶基吡啶酮衍生物
|
|
JP2025508714A
(ja)
*
|
2022-02-16 |
2025-04-10 |
デューク ストリート バイオ リミテッド |
医薬化合物
|
|
EP4626878A1
(en)
|
2022-12-02 |
2025-10-08 |
Neumora Therapeutics, Inc. |
Methods of treating neurological disorders
|